CDMO(CDMO)
CDMO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $225M | $255M | $283M |
| Low | $217M | $255M | $283M |
| High | $233M | $255M | $283M |
| EBITDA Avg | $9M | $10M | $11M |
| Low | $9M | $10M | $11M |
| High | $9M | $10M | $11M |
| EBIT Avg | $-2M | $-3M | $-3M |
| Low | $-3M | $-3M | $-3M |
| High | $-2M | $-3M | $-3M |
| Net Income Avg | $11M | — | — |
| Low | $11M | — | — |
| High | $11M | — | — |
| EPS Avg | $0.18 | — | — |
| Low | $0.18 | — | — |
| High | $0.18 | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / — | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $57M | $45M | $58M | $66M |
| Low | $57M | $45M | $58M | $66M |
| High | $57M | $45M | $58M | $66M |
| EBITDA Avg | $2M | $2M | $2M | $3M |
| Low | $2M | $2M | $2M | $3M |
| High | $2M | $2M | $2M | $3M |
| EBIT Avg | $-626,135 | $-492,300 | $-641,445 | $-728,871 |
| Low | $-626,135 | $-492,300 | $-641,445 | $-728,871 |
| High | $-626,135 | $-492,300 | $-641,445 | $-728,871 |
| Net Income Avg | $2M | $-1M | $2M | $6M |
| Low | $2M | $-1M | $2M | $6M |
| High | $2M | $-1M | $2M | $6M |
| EPS Avg | $0.03 | $-0.02 | $0.03 | $0.09 |
| Low | $0.03 | $-0.02 | $0.03 | $0.09 |
| High | $0.03 | $-0.02 | $0.03 | $0.09 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |